The Future of Epilepsy More than a third of the 2.7 million epilepsy patients in the US have persistent seizures using existing therapies. Many others tolerate serious side effects, including diminished cognition, as a price for seizure control. New therapies introduced over the last decade offer fewer side effects but have done little to bring effective seizure control to the significant population living with active and uncontrolled epilepsy. As such, this episode is designed to not only to raise awareness of this unmet need but to encourage the discovery of future therapies. Patients and their families with share their compelling stories describing how they deal with these issues and hope for changes.